Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Almería
Clinical trial register · Spain

Clinical Trials in Almería, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Universidad de Almeria9 Eli Lilly and Company6 AstraZeneca4 AbbVie3 Hoffmann-La Roche2
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Almería

60 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Universidad de Almeria
Not applicable
60
Almería
2027-09-01
Not yet open
Universidad de Almeria
Not applicable
100
Almería
2027-01
Not yet open
Predictive Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae
NCT07396571Hemato-oncologic Patients, Colonization, Neutropenia, Enterobacteria Non Susceptible to Carbapenem Carrier
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Observational
535
Almería, Jerez de la Frontera, Vigo, Pamplona, Barcelona, Cadiz, Granada, Huelva
2026-09-04
Recruiting
Novo Nordisk A/S
Phase 3
450
Fuenlabrada, Almería, Castilleja de la Cuesta, Ferrol, Madrid, Santiago de Compostela, Seville
2026-08-12
Recruiting
AstraZeneca
Phase 3
4,500
A Coruña, Almería, Badalona, Barcelona, León, Madrid, Santander, Santiago de Compostela
2026-06-29
Not yet open
Universidad de Almeria
Phase 3
156
Almería
2026-06-01
Not yet open
Impact of Circadian Exercise on Metabolic Dysfunction-Associated Steatotic Liver Disease in Postmenopausal Women
NCT07386665Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiometabolic Diseases, Exercise
Universidad de Almeria
Not applicable
63
Almería
2026-06-01
Active, closed
Novo Nordisk A/S
Phase 3
606
Almería, Barcelona, León, Madrid, Málaga, Pozuelo de Alarcón, Seville
2026-04-21
Not yet open
Elena Pérez Expósito, MD
Not applicable
86
Almería
2026-03-16
Not yet open
Treatment for Ph-negative ALL for Adults up to 65 Years
NCT07443592Acute Lymphoblastic Leukemia
PETHEMA Foundation
Not applicable
330
A Coruña, Alava, Albacete, Alicante, Almería, Arrecife, Ávila, Badajoz
2026-03-06
Recruiting
Instituto de Investigación Biomédica de Salamanca
Phase 3
300
Salamanca, Almería, Barakaldo, Girona, Las Palmas de Gran Canaria, Madrid, Murcia, Santander
2026-03-01
Recruiting
Boehringer Ingelheim
Phase 3
286
Almería, Barcelona, Granada, Madrid
2026-02-16
Recruiting
ViiV Healthcare
Phase 2
186
A Coruña, Alicante, Almería, Badalona, Barcelona, Elche Alicante, Getafe, Granada
2026-02-11
Recruiting
Eli Lilly and Company
Phase 3
900
A Coruña, Almería, Barcelona, Ferrol, Palma de Mallorca, Pozuelo de Alarcón, Santander, Seville
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
7,140
Almería, Alzira, Badajoz, Badalona, Barcelona, Boadilla del Monte, Lugo, Majadahonda
2025-12-01
Recruiting
AbbVie
Observational
103
Málaga, Palma, Badalona, Santander, Cartagena, Gijón, Seville, Almería
2025-11-17
Active, closed
Universidad de Almeria
Not applicable
60
Almería
2025-10-01
Recruiting
Mirum Pharmaceuticals, Inc.
Phase 3
172
Almería, Barcelona, Madrid, Málaga, Santander, Vigo
2025-08-27
Recruiting
Hoffmann-La Roche
Observational
700
Almería, Palma de Mallorca, Manresa, Puerto Real, Alcázar de San Juan, Santiago de Compostela, Oviedo, Reus
2025-07-15
Active, closed
Universidad de Almeria
Not applicable
100
Almería
2025-06-30
Recruiting
Study of Ravulizumab in Pediatric Participants With Primary IgAN
NCT07024563IgAN, IgAVN, Immunoglobulin A Nephropathy, Immunoglobulin A Vasculitis Associated Nephritis
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
36
Almería, Barcelona, Seville
2025-06-14
Recruiting
Universidad de Almeria
Not applicable
172
Almería
2025-06-01
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
400
A Coruña, Almería, Barcelona, Madrid, Málaga, Seville, Tarragona, Zaragoza
2025-04-10
Active, closed
Hoffmann-La Roche
Phase 2
30
Esplugues de Llobregas, Asturias, Almería, Valencia
2025-04-04
Active, closed
Amgen
Phase 3
3,853
Almería, Castilleja de la Cuesta, Huelva, Sanlúcar de Barrameda, Seville, A Coruña, Pozuelo de Alarcón, Pamplona
2025-03-12
Recruiting
AstraZeneca
Phase 3
5,000
A Coruña, Almería, Badalona, L'Hospitalet de Llobregat, Majadahonda, Málaga, Palma deMallorca, Pamplona
2025-03-03
Active, closed
Procare Health Iberia S.L.
Observational
300
Sitges, Getafe, Benalmádena, Estella-Lizarra, A Coruña, Alicante, Almería, Barcelona
2025-02-13
Recruiting
Hospital Universitario de Valme
Observational
9,000
Almería, Cadiz, Cartagena, Córdoba, Cuenca, Elche, Granada, Huelva
2025-01-01
Recruiting
Spanish Oncology Genito-Urinary Group
Observational
500
Albacete, Alicante, Almería, Córdoba, Granada, Jaén, Jerez de la Frontera, Málaga
2024-12-13
Recruiting
Universidad de Almeria
Not applicable
96
Almería, Granada
2024-11-15
Active, closed
Ipsen
Observational
424
Almería, Barcelona, Madrid, Pontevedra, Santander
2024-10-14
Recruiting
Fundación para la investigación biomética Hospital Infantil Universitario Niño Jesús
Not applicable
42
A Coruña, Almería, Seville, Palma, Salamanca, Barcelona, Donostia / San Sebastian, Madrid
2024-10-01
Recruiting
IRCCS Sacro Cuore Don Calabria di Negrar
Not applicable
278
Almería, Barcelona
2024-06-28
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Almería, Badalona, Barcelona, Córdoba, Madrid, Málaga, Pontevedra, Santander
2024-05-24
Active, closed
Eli Lilly and Company
Phase 3
10,000
A Coruña, Almería, Alzira, Barcelona, Ferrol, Málaga, Oviedo, Palma de Mallorca
2024-04-30
Active, closed
AstraZeneca
Phase 3
2,554
A Coruña, Almería, Badalona, L'Hospitalet de Llobregat, Lugo, Madrid, Málaga, Palma deMallorca
2024-03-29
Recruiting
Whole-Body Vibration Therapy in the Gait of Children With Cerebral Palsy
NCT06314776Cerebral Palsy, Neurologic Disorder, Gait Disorders in Children, Hemiplegia
Universidad de Almeria
Not applicable
10
Almería
2024-03-11
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
78
Almería, Barcelona, Madrid
2024-03-04
Active, closed
iVascular S.L.U.
Phase 3
2,312
A Coruña, Almería, Barcelona, Cáceres, Huelva, Jerez de la Frontera, Las Palmas de Gran Canaria, León
2023-10-13
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Pamplona, Almería, Barcelona, Madrid, Salamanca
2023-10-02
Recruiting
PICAROS - Acalabrutinib RWE on 1L CLL in Spain
NCT05999877Chronic Lymphocytic Leukemia
AstraZeneca
Observational
315
Almería, Córdoba, Granada, Jaén, Marbella, Málaga, Seville, Zaragoza
2023-07-11
Active, closed
Eli Lilly and Company
Phase 3
3,127
A Coruña, Ferrol, Almería, Málaga, Seville, Badalona, Barcelona, Valladolid
2023-06-05
Recruiting
Fundación Española de Hematología y Hemoterapía
Observational
210
Vitoria-Gasteiz, Almería, Palma de Mallorca, Sabadell, Burgos, Valdepeñas, Girona, Granada
2023-05-30
Recruiting
University of Malaga
Not applicable
195
Almería, Barcelona, Granada, Madrid, Cartagena, Málaga
2023-05-05
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
A Coruña, Almería, Barcelona, Cabra, Granada, Jaén, León, Madrid
2022-12-27
Recruiting
Regeneron Pharmaceuticals
Observational
500
Málaga, Sabadell, Jerez de la Frontera, Castellon, Ferrol, Vigo, Almería, Jaén
2022-10-26
Active, closed
Eli Lilly and Company
Phase 3
15,374
A Coruña, Almería, Alzira, Barcelona, Bilbao, Ferrol, Granada, León
2022-10-11
Active, closed
Eli Lilly and Company
Phase 3
8,000
A Coruña, Alicante, Almería, Badajoz, Barcelona, Bilbao, Burgos, Cáceres
2022-10-04
Active, closed
AbbVie
Observational
785
L'Hospitalet de Llobregat, Sabadell, Las Palmas de Gran Canaria, Gijón, San Cristóbal de La Laguna, Seville, Galdakao, Almería
2022-08-15
Recruiting
Dimerix Bioscience Pty Ltd
Phase 3
286
Almería, Barcelona, Córdoba, Madrid, Majadahonda, Seville
2022-05-30
Recruiting
Hospital Universitario de Fuenlabrada
Phase 4
216
Elche, Almería, Badajoz, Sant Joan Despí, Castellon, Ciudad Real, Córdoba, San Sebastián
2022-03-02
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
A Coruña, Alicante, Almería, Barcelona, Córdoba, Granada, Madrid, Málaga
2022-02-07
Active, closed
Inventiva Pharma
Phase 3
1,000
Almería, Badalona, Palma de Mallorca, Barcelona, Sabadell, León, Madrid, Majadahonda
2021-08-19
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Almería, Badalona, Barcelona, Boadilla del Monte, Córdoba, El Palmar, Fuencarral-El Pardo, Huelva
2021-08-14
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Albacete, Alcorcón, Alcoy, Alicante, Almería, Asturias, Badajoz, Barakaldo
2021-01-15
Active, closed
Goat Infant Formula Feeding and Eczema (the GIraFFE Study)
NCT04599946Dermatitis, Atopic, Eczema, Infantile, Infant Development, Child Development
Dairy Goat Co-operative (N.Z.) Limited
Not applicable
2,132
Almería, Granada, Madrid, Reus, Tarragona, Valencia, Zaragoza
2021-01-08
Recruiting
University Hospital Muenster
Phase 3
683
Alicante, Almería, Badajoz, Barakaldo, Barcelona, Donostia / San Sebastian, Esplugues de Llobregat, Granada
2019-08-23
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Majadahonda, Almería, Barcelona, Madrid, Pontevedra, Santander, Seville, Valencia
2019-03-28
Active, closed
AbbVie
Phase 3
964
Badalona, Sabadell, A Coruña, Almería, Barcelona, Madrid, Valencia
2019-03-25
Active, closed
Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome
NCT01934725Brain Infarction, Ischemic Stroke, Thrombosis, Foramen Ovale, Patent
SECRETO Study Consortium
Observational
1,200
Almería
2013-11
Rows per page Showing 1–60 of 60
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/almer-a

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 60 of those studies with a site in Almería.

How many clinical trials are recruiting in Almería?

30 of the 60 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 7 have not yet opened recruitment, 21 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Almería), 60 studies
PhaseStudiesRecruitingShare
Phase 3281446.7%
Not applicable15725%
Observational13721.7%
Phase 2213.3%
Phase 1/2101.7%
Phase 4111.7%

Most active sponsors

Lead sponsors with the most studies (Almería)
Lead sponsorStudiesRecruiting
Universidad de Almeria93
Eli Lilly and Company62
AstraZeneca43
AbbVie31
Hoffmann-La Roche21
Novo Nordisk A/S21
89bio, Inc.11
Alexion Pharmaceuticals, Inc.11
Amgen10
Anthos Therapeutics, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.